Skip to main content
Clinical Trials/ACTRN12609000524291
ACTRN12609000524291
Not Yet Recruiting
Phase 4

Do subjects with symptomatic knee osteoarthritis demonstrate more widespread mechanical and cold hyperalgesia compared with matched controls, and can this hyperalgesia be better modified by a 2-week course of Arcoxia than placebo?

Curtin University of technology0 sites80 target enrollmentJuly 1, 2009

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
osteoarthritis
Sponsor
Curtin University of technology
Enrollment
80
Status
Not Yet Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 1, 2009
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Curtin University of technology

Eligibility Criteria

Inclusion Criteria

  • i) unilateral diagnosis of Knee Osteoarthritis (OA) \>6 months
  • ii) knee pain \>4/10 on WOMAC pain subscale
  • iii) if pain in contralateral knee, no greater than mild
  • iv) no other significant joint involvement
  • v) American Rheumatology Association (ARA) functional Class I, II or III
  • vi) no athroscopy or injections into index knee in last 6 months.

Exclusion Criteria

  • i) history of systemic inflammatory or chronic pain disorders (especially fibromyalgia)
  • ii) neurological deficit
  • iii) recent (\<6 months) lower limb surgery
  • iv) allergic reaction to Non\-steroidal anti\-inflammatory drugs (NSAIDs) or aspirin
  • v) skin allergies, dermatitis
  • vi) contraindications to Cox\-2 inhibitors: congestive heart failure (New York Heart Association Classifications II\-IV); unstable hypertension; ischaemic heart disease, peripheral artery disease, cerebrovascular disease including coronary artery bypass graft or angioplasty within 1 year; severe hepatic dysfunction; active gastro\-intestinal tract bleeding or peptic ulceration; reduced creatinine clearance \<30mL/min
  • vii) current use of high dose (\>325mg daily) aspirin

Outcomes

Primary Outcomes

Not specified

Similar Trials